November 2, 2016
India’s Koanna gets UK’s MHRA OK for Imatinib tablets
India’s Koanna gets marketing approval from MHRA for Imatinib tablets
Pharmaceuticals, Biotechnology and Life Sciences
Category: Asia
November 1, 2016
USFDA opens door to $30M market for India’s Strides Shasun’s HIV-1 infection tablets
India’s Strides Shasun Limited has received approval from the USFDA for Abacavir Tablets
October 25, 2016
Bangladesh’s Beximco gets its second US FDA product approval
Bangladesh-based Beximco, the largest country’s pharmaceutcals exporter, has received its second US FDA …
October 19, 2016
Beximco Pharmaceutical to declare cash and stock dividends at next AGM
A Bangladesh based, AIM listed Beximco Pharmaceuticals has announced that it would declare/approve 5% final Cash Dividend, 5% Stock Dividend and 10% Cash Dividend
March 7, 2016
Pharma crusader takes India’s drug regulators to court
One of India’s best-known whistleblowers, who exposed dangerous practices in the generic drug industry in 2013, is taking the country’s drugs regulators to court, accusing them of failing to enforce rules on drug safety in the $15 billion (11 billion pound) industry.
January 21, 2016
Glenmark Pharmaceuticals entering $130M market with two new generic medicines
Glenmark Pharmaceuticals entering $130M market with Actavis’ Potassium Cholire capsules and generics of Warner Chilcott’s Loestrin tablets
January 21, 2016
Indian Natco to sell Bristol-Myer Squibb’s hepatitis C medicine in 112 countries
Indian pharmaceutical company Natco Pharma Limited has signed a nonexclusive, royalty free licensing agreement with the Medicines Patent Pool and…
January 5, 2016
Glenmark confirms reaching agreement with Roche over patent disputes
Glenmark confirms reaching agreement with Roche over patent disputes
January 5, 2016
Suven’s products gets three patent grants; from Canada, ARIPO, and South Korea
Suven Life Sciences Ltd has announced that the grand of one product patent from Canada, one from ARIPO and one from South Korea corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2030.
December 31, 2015
Brooks Laboratories’ new manufacturing unit in Vadodra to kick off production in 3 months
Brooks Laboratories’ new manufacturing unit in Vadodra to kick off production in 3 months